Polpharma B2B Announces New Vice-President
Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer...
This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development.
Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use.
Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer...
Polpharma B2B is a significant European active pharmaceutical ingredient (API) producer with current good manufacturing...
Polpharma B2B's team of experts will be pleased to meet you at the CPhI Worldwide...
Polpharma B2B has announced it will be attending CPhI Worldwide 2018 in Madrid. The event...